Blood Pressure Medication recalls

The FDA has published 837 recalls involving blood pressure medication since 2012. The latest was reported on 23 Sep 2026. Most were for potency & assay. Aidapak Services has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls837since 2012

Last 12 months29reported

Class I81% of total

Ongoing198latest 23 Sep 2026

Recalls per month, last 24 months

click a bar for that month

5Nov '24 7 2 6Feb 0 2 0May 5 2 11Aug 0 0 7Nov 2 0 2Feb 4 6 2May 2 1 1Aug 2 0

Severity split

Class I 8 1%Class II 704 84%Class III 125 15%

Why blood pressure medication is recalled

Companies

Brands

Valsartan192%
Losartan Potassium192%
Carvedilol172%
Losartan Potassium And Hydrochlorothiazide162%
Metoprolol Succinate162%
Valsartan And Hydrochlorothiazide162%
Amlodipine And Valsartan121%
Amlodipine Besylate And Atorvastatin Calcium111%

By year

2026202%
2025374%
2024304%
2023324%
2022769%
2021324%
2020293%
201912815%
201814918%
2017233%

Ongoing blood pressure medication recalls

198 active

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg recalled by Inventia HealthcareChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Ramipril Capsules USP, 10 mg recalled by Hikma Pharmaceuticals USARamipril	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
19 Aug 2026Drug	CLASS II	Diovan (valsartan) 160 mg recalled by Novartis PharmaceuticalsDiovan	Novartis Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
24 Jun 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr recalledChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
10 Jun 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide

All blood pressure medication recalls, newest first

837 total

Reported	Class	Recall	Company	Reason	Where
23 Sep 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg recalled by Inventia HealthcareChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
2 Sep 2026Drug	CLASS II	Ramipril Capsules USP, 10 mg recalled by Hikma Pharmaceuticals USARamipril	Hikma Pharmaceuticals USA	Potency & Assay	Nationwide
19 Aug 2026Drug	CLASS II	Diovan (valsartan) 160 mg recalled by Novartis PharmaceuticalsDiovan	Novartis Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
24 Jun 2026Drug	CLASS II	Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr recalledChlorthalidone	Inventia Healthcare	Potency & Assay	Nationwide
10 Jun 2026Drug	CLASS II	Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan Medoxomil	Ascend Laboratories	Potency & Assay	Nationwide
20 May 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 25 mg* recalledMetoprolol Succinate	Ascend Laboratories	Potency & Assay	Nationwide
13 May 2026Drug	CLASS II	Enalapril Maleate Tablets, USP, 20 mg recalled by JB Chemicals andEnalapril Maleate	JB Chemicals and Pharmaceuticals	Potency & Assay	Nationwide
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.3 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.1 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
15 Apr 2026Drug	CLASS II	Clonidine Transdermal System, USP, 0.2 mg/day, supplied recalledClonidine Transdermal System	Teva Pharmaceuticals USA	Manufacturing (CGMP) Deviations	NJ
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 5mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 2mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
8 Apr 2026Drug	CLASS II	Prazosin Hydrochloride Capsules, USP, 1mg recalled by Appco PharmaPrazosin Hydrochloride	Appco Pharma	Nitrosamine Impurity	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
18 Feb 2026Drug	CLASS III	Doxazosin Tablets, USP, 4 mg recalled by Unichem Pharmaceuticals USADoxazosin Mesylate	Unichem Pharmaceuticals USA	Other	Nationwide
11 Feb 2026Drug	CLASS II	Bisoprolol Fumarate and Hydrochlorothiazide tablets recalledBisoprolol Fumarate And Hydrochlorothiazide	Unichem Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
17 Dec 2025Drug	CLASS III	Nebivolol Tablets, 20 mg recalled by Glenmark PharmaceuticalsNebivolol	Glenmark Pharmaceuticals Inc., USA	Other	Nationwide
10 Dec 2025Drug	CLASS III	Bisoprolol Fumarate and Hydrochlorothiazide Tablets recalled	Glenmark Pharmaceuticals Inc., USA	Packaging Defects	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 5 mg recalledPrazosin Hydrochloride	Teva Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	R.E.C.K. (Ropivacaine HCl, EPINEPHrine, CloNIDine HCl recalled	QuVa Pharma	Particulate Matter	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 1 mg recalledPrazosin Hydrochloride	Amerisource Health Services	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 2 mg recalledPrazosin Hydrochloride	Amerisource Health Services	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 5 mg recalledPrazosin Hydrochloride	Amerisource Health Services	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 1 mg recalledPrazosin Hydrochloride	Teva Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
5 Nov 2025Drug	CLASS II	Prazosin Hydrochloride, Capsules, USP, 2 mg recalledPrazosin Hydrochloride	Teva Pharmaceuticals USA	Nitrosamine Impurity	Nationwide
27 Aug 2025Drug	CLASS II	Carvedilol Tablets USP, 12.5 mg recalled by The Harvard Drug GroupCarvedilol	The Harvard Drug Group	Nitrosamine Impurity	Nationwide

Should you stop taking Blood Pressure Medication?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.

Alert me about Blood Pressure Medication

One email the day a new recall is posted for Blood Pressure Medication. Unsubscribe any time.

At a glance

Latest recall: 23 Sep 2026
First on record: 11 Jul 2012
Class I share: 1%
Ongoing: 198

Drug classes

Injectable & IV Drugs 4,626Pain Medication 1,518Creams, Ointments & Gels 930Blood Pressure Medication 837Compounded Drugs 721Eye Drops 600Hormones & Birth Control 495Antibiotics 492Allergy Medication 348Stomach & Acid Reflux Medication 313Cold & Cough Medicine 312Diabetes Medication 242

Recall classes

CLASS ISerious harm or death possible.

CLASS IITemporary or reversible harm.

CLASS IIIUnlikely to cause harm.